Kim Soohyung
Director · Ten-percent owner · BALY
As of 2026-09-16, Kim Soohyung has 15 Form 4 transactions on record across 1 company — 7 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Reconstructed holdings
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|
15 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-06-01 | BALY | Award / grant | 32,877 | 32,877 | Form 4 |
| 2025-12-31 | BALY | Award / grant | 3,027 | 64,080 | Form 4 |
| 2025-12-22 | BALY | Other acquisition | 623,875 | 32,480,973 | Form 4 |
| 2025-12-22 | BALY | Other acquisition | 623,875 | 32,480,973 | Form 4 |
| 2025-12-22 | BALY | Other acquisition | 623,875 | 32,480,973 | Form 4 |
| 2025-11-24 | BALY | Other acquisition | 254,896 | 33,104,848 | Form 4 |
| 2025-09-30 | BALY | Award / grant | 4,505 | 61,053 | Form 4 |
| 2025-09-16 | BALY | Other acquisition | 2,400,000 | 33,359,744 | Form 4 |
| 2025-06-30 | BALY | Award / grant | 5,219 | 56,548 | Form 4 |
| 2025-05-15 | BALY | Award / grant | 18,450 | 51,329 | Form 4 |
| 2025-03-31 | BALY | Award / grant | 4,065 | 32,879 | Form 4 |
| 2025-02-07 | BALY | Award / grant | 26,909,895 | 35,759,744 | Form 4 |
| 2025-02-07 | BALY | Award / grant | 26,909,895 | 35,759,744 | Form 4 |
| 2025-02-07 | BALY | Award / grant | 26,909,895 | 35,759,744 | Form 4 |
| 2024-12-31 | BALY | Award / grant | 2,795 | 28,814 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.